nodes	percent_of_prediction	percent_of_DWPC	metapath
Bifonazole—CYP17A1—Dexamethasone—psoriasis	0.203	0.219	CbGbCtD
Bifonazole—CYP19A1—Betamethasone—psoriasis	0.136	0.147	CbGbCtD
Bifonazole—CYP19A1—Dexamethasone—psoriasis	0.079	0.0853	CbGbCtD
Bifonazole—CYP2B6—Cholecalciferol—psoriasis	0.0753	0.0813	CbGbCtD
Bifonazole—CYP2C19—Cholecalciferol—psoriasis	0.0478	0.0517	CbGbCtD
Bifonazole—CYP3A4—Calcitriol—psoriasis	0.0449	0.0485	CbGbCtD
Bifonazole—CYP3A4—Methoxsalen—psoriasis	0.0349	0.0377	CbGbCtD
Bifonazole—CYP2C19—Prednisone—psoriasis	0.0332	0.0358	CbGbCtD
Bifonazole—CYP2E1—Dexamethasone—psoriasis	0.033	0.0357	CbGbCtD
Bifonazole—CYP2B6—Dexamethasone—psoriasis	0.0326	0.0352	CbGbCtD
Bifonazole—CYP2C19—Cyclosporine—psoriasis	0.0314	0.0339	CbGbCtD
Bifonazole—CYP3A4—Cholecalciferol—psoriasis	0.0231	0.025	CbGbCtD
Bifonazole—CYP2C19—Dexamethasone—psoriasis	0.0207	0.0223	CbGbCtD
Bifonazole—CYP3A4—Triamcinolone—psoriasis	0.0201	0.0216	CbGbCtD
Bifonazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.0201	0.0216	CbGbCtD
Bifonazole—CYP3A4—Betamethasone—psoriasis	0.0172	0.0186	CbGbCtD
Bifonazole—CYP3A4—Prednisolone—psoriasis	0.017	0.0183	CbGbCtD
Bifonazole—CYP3A4—Hydrocortisone—psoriasis	0.0161	0.0174	CbGbCtD
Bifonazole—CYP3A4—Prednisone—psoriasis	0.016	0.0173	CbGbCtD
Bifonazole—CYP3A4—Cyclosporine—psoriasis	0.0152	0.0164	CbGbCtD
Bifonazole—CYP3A4—Dexamethasone—psoriasis	0.01	0.0108	CbGbCtD
Bifonazole—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00412	0.0558	CbGpPWpGaD
Bifonazole—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00403	0.0546	CbGpPWpGaD
Bifonazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.0032	0.0434	CbGpPWpGaD
Bifonazole—CYP51A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00316	0.0428	CbGpPWpGaD
Bifonazole—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00311	0.0421	CbGpPWpGaD
Bifonazole—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00272	0.0369	CbGpPWpGaD
Bifonazole—CYP17A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00269	0.0364	CbGpPWpGaD
Bifonazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0026	0.0352	CbGpPWpGaD
Bifonazole—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00255	0.0346	CbGpPWpGaD
Bifonazole—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.0025	0.0339	CbGpPWpGaD
Bifonazole—CYP17A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00221	0.0299	CbGpPWpGaD
Bifonazole—CYP51A1—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00216	0.0293	CbGpPWpGaD
Bifonazole—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00193	0.0261	CbGpPWpGaD
Bifonazole—CYP51A1—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00173	0.0234	CbGpPWpGaD
Bifonazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00165	0.0224	CbGpPWpGaD
Bifonazole—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00163	0.0221	CbGpPWpGaD
Bifonazole—CYP51A1—Biological oxidations—CYP2S1—psoriasis	0.00138	0.0187	CbGpPWpGaD
Bifonazole—CYP51A1—Metapathway biotransformation—CYP2S1—psoriasis	0.00136	0.0184	CbGpPWpGaD
Bifonazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00134	0.0181	CbGpPWpGaD
Bifonazole—CYP17A1—Biological oxidations—CYP2S1—psoriasis	0.00117	0.0159	CbGpPWpGaD
Bifonazole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00116	0.0157	CbGpPWpGaD
Bifonazole—CYP17A1—Metapathway biotransformation—CYP2S1—psoriasis	0.00116	0.0157	CbGpPWpGaD
Bifonazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00106	0.0144	CbGpPWpGaD
Bifonazole—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00105	0.0142	CbGpPWpGaD
Bifonazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00104	0.0141	CbGpPWpGaD
Bifonazole—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00102	0.0139	CbGpPWpGaD
Bifonazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000859	0.0116	CbGpPWpGaD
Bifonazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000842	0.0114	CbGpPWpGaD
Bifonazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000801	0.0108	CbGpPWpGaD
Bifonazole—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	0.000796	0.0108	CbGpPWpGaD
Bifonazole—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00079	0.0107	CbGpPWpGaD
Bifonazole—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.000711	0.00963	CbGpPWpGaD
Bifonazole—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000701	0.00949	CbGpPWpGaD
Bifonazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000649	0.00879	CbGpPWpGaD
Bifonazole—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000613	0.00831	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000598	0.0081	CbGpPWpGaD
Bifonazole—CYP51A1—SREBP signalling—PPARG—psoriasis	0.000582	0.00789	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000487	0.00659	CbGpPWpGaD
Bifonazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000482	0.00652	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000477	0.00646	CbGpPWpGaD
Bifonazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000475	0.00644	CbGpPWpGaD
Bifonazole—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000456	0.00618	CbGpPWpGaD
Bifonazole—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.00045	0.0061	CbGpPWpGaD
Bifonazole—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000447	0.00606	CbGpPWpGaD
Bifonazole—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000441	0.00597	CbGpPWpGaD
Bifonazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00039	0.00529	CbGpPWpGaD
Bifonazole—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000386	0.00522	CbGpPWpGaD
Bifonazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000385	0.00522	CbGpPWpGaD
Bifonazole—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000345	0.00467	CbGpPWpGaD
Bifonazole—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00034	0.00461	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000339	0.0046	CbGpPWpGaD
Bifonazole—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000334	0.00453	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000332	0.0045	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—NDUFA5—psoriasis	0.000277	0.00376	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000259	0.0035	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—CYP2S1—psoriasis	0.000236	0.0032	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—NDUFA5—psoriasis	0.000236	0.0032	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000221	0.003	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.00022	0.00298	CbGpPWpGaD
Bifonazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000207	0.00281	CbGpPWpGaD
Bifonazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000205	0.00277	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—CYP2S1—psoriasis	0.000201	0.00272	CbGpPWpGaD
Bifonazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000199	0.00269	CbGpPWpGaD
Bifonazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000179	0.00242	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000154	0.00209	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—NDUFA5—psoriasis	0.000143	0.00194	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000133	0.00181	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000124	0.00167	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—CYP2S1—psoriasis	0.000122	0.00165	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—CARM1—psoriasis	0.000115	0.00156	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000114	0.00154	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.000109	0.00148	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000108	0.00146	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000105	0.00142	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	9.94e-05	0.00135	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—CARM1—psoriasis	9.8e-05	0.00133	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—NDUFA5—psoriasis	9.18e-05	0.00124	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.16e-05	0.00124	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—NDUFA5—psoriasis	8.99e-05	0.00122	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—CYP2S1—psoriasis	7.81e-05	0.00106	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—CYP2S1—psoriasis	7.64e-05	0.00104	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	7.51e-05	0.00102	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—CAT—psoriasis	7.09e-05	0.00096	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—NDUFA5—psoriasis	6.94e-05	0.00094	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.47e-05	0.000876	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.37e-05	0.000863	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—CAT—psoriasis	6.03e-05	0.000816	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—CARM1—psoriasis	5.94e-05	0.000804	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—CYP2S1—psoriasis	5.9e-05	0.000799	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.55e-05	0.000751	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—APOE—psoriasis	5.51e-05	0.000746	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—PPARG—psoriasis	4.8e-05	0.00065	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—APOE—psoriasis	4.68e-05	0.000634	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—NDUFA5—psoriasis	4.17e-05	0.000565	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—PPARG—psoriasis	4.08e-05	0.000552	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—CARM1—psoriasis	3.81e-05	0.000516	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—CARM1—psoriasis	3.73e-05	0.000506	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—CAT—psoriasis	3.65e-05	0.000495	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—CYP2S1—psoriasis	3.55e-05	0.00048	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.09e-05	0.000419	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—CARM1—psoriasis	2.88e-05	0.00039	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—APOE—psoriasis	2.84e-05	0.000384	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.69e-05	0.000365	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—PPARG—psoriasis	2.47e-05	0.000335	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—CAT—psoriasis	2.34e-05	0.000318	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—CAT—psoriasis	2.3e-05	0.000311	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—APOE—psoriasis	1.82e-05	0.000247	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—APOE—psoriasis	1.78e-05	0.000242	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—CAT—psoriasis	1.77e-05	0.00024	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—CARM1—psoriasis	1.73e-05	0.000235	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—PPARG—psoriasis	1.59e-05	0.000215	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—PPARG—psoriasis	1.55e-05	0.000211	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—APOE—psoriasis	1.38e-05	0.000186	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—PPARG—psoriasis	1.2e-05	0.000162	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—CAT—psoriasis	1.07e-05	0.000144	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—APOE—psoriasis	8.28e-06	0.000112	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—PPARG—psoriasis	7.21e-06	9.77e-05	CbGpPWpGaD
